期刊文献+

成人甲状腺结节与分化型甲状腺癌诊治指南(2015年美国甲状腺协会)解读 被引量:271

The interpretation of 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer
原文传递
导出
摘要 甲状腺结节特别是分化型甲状腺癌(differentiated thyroid carcinoma,DTC)近年来呈高发趋势。随着患者数量以及相关研究的增加,2015年美国甲状腺协会(American Thyroid Association,ATA)更新了甲状腺结节与DTC治疗指南。指南中明确提出其主要目标是:减小对大多数与疾病相关的死亡、复发的风险,并降低对患者的过度治疗带来的潜在危害,而给予高危险患者恰当的治疗和监控。本文对2015年ATA《成人甲状腺结节与分化型甲状腺癌诊治指南》做一解读,主要内容包括:甲状腺结节的筛查、诊断与治疗计划,分化型甲状腺癌的初始外科治疗,分化型甲状腺癌手术后的评估与治疗,分化型甲状腺癌的随访,以及病灶复发/持续存在、远处转移的诊治。 The prevalence of thyroid nodules, especially differentiated thyroid cancer, has increased during the past decades. With the consideration of increasing prevalence of the diseases, American Thyroid Association (ATA) updated the guidelines for adult patients with thyroid nodules and differentiated thyroid carcinoma (DTC) in 2015. The aim of the new guidelines was to minimize potential harm from overtreatment in majority of patients at low risk for diseasespecific mortality and morbidity while appropriately treat and monitor those patients at higher risk. The updates of contents in new ATA guidelines are interpreted in this article, including the contents about screening, diagnosis and treatment plan of nodules, initial surgical treatment of DTC, the evaluation and treatment of DTC after surgery, follow-up and diagnosis and treatment of recurrence, persistence, and distant metastasis of DTC.
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2017年第4期309-315,共7页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
关键词 甲状腺肿瘤 甲状腺结节 实践指南 Thyroid neoplasms Thyroid nodules Practice guidelines
  • 相关文献

二级参考文献85

  • 1GANLY I, NIXON I J, WANG L Y, et al. Survival fromdifferentiated thyroid cancer: What has age got to do with it?[J]Thyroid, 2015, 25(10): 1106-1114.
  • 2National Cancer Institute. SEER Cancer Statistics Factsheets:Thyroid Cancer. [EB/OL]. http://seer.cancer.gov/statfacts/html/thyro.html, 2015-10-08.
  • 3DAVIES L, WELCH H G. Increasing incidence of thyroidcancer in the United States, 1973-2002 [J]. JAMA, 2006,295(18): 2164-2167.
  • 4MAZZAFERRI E L. Management of low-risk differentiatedthyroid cancer [J]. Endocr Pract, 2007, 13(5): 498-512.
  • 5ROTI E, DEGLI UBERTI E C, BONDANELLI M, et al.Thyroid papillary microcarcinoma: a descriptive and metaanalysisstudy [J]. Eur J Endocrinol, 2008, 159(6): 659-673.
  • 6ITO Y, KUDO T, KIHARA M, et al. Prognosis of low-riskpapillary thyroid carcinoma patients: its relationship with thesize of primary tumors [J]. Endocr J, 2012, 59(2): 119-125.
  • 7WU M H, SHEN W T, GOSNELL J, et al. Prognosticsignificance of extranodal extension of regional lymphnode metastasis in papillary thyroid cancer [J]. HeadNeck, 2015, 37(9): 1336- 1343.
  • 8PARK Y M, WANG S G, LEE J C, et al. Metastatic lymphnode status in the central compartment of papillary thyroidcarcinoma: A prognostic factor of locoregional recurrence[J]. Head Neck, 2015, 13 [Epub ahead of print]. doi:10.1002/hed.24186.
  • 9RANDOLPH G W, DUH Q Y, HELLER K S, et al. Theprognostic significance of nodal metastases from papillarythyroid carcinoma can be stratified based on the size andnumber of metastatic lymph nodes, as well as the presenceof extranodal extension [J]. Thyroid, 2012, 22(11): 1144-1152.
  • 10LEE J, SONG Y, SOH E Y. Prognostic significance of thenumber of metastatic lymph nodes to stratify the risk ofrecurrence [J]. World J Surg, 2014, 38(4): 858-862.

共引文献335

同被引文献2004

引证文献271

二级引证文献1548

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部